Literature DB >> 31144606

An inverse interaction between HOXA11 and HOXA11-AS is associated with cisplatin resistance in lung adenocarcinoma.

Youwei Zhang1, Yuan Yuan1, Yang Li2, Peiying Zhang1, Pingsheng Chen3, Sanyuan Sun1.   

Abstract

HOXA11, which is a member of the homeobox (HOX) gene family, and its natural antisense transcript (NAT) HOXA11-AS have been reported to be closely related to the development of lung cancer. We aimed to investigate their specific roles in cisplatin (DDP) resistance in lung adenocarcinoma (LUAD). First, we found that HOXA11 is hypermethylated and significantly downregulated in a DDP-resistant A549 cell line (A549/DDP) and LUAD tissues, while the HOXA11-AS expression level is elevated. Although HOXA11 and HOXA11-AS mRNA overlap in the 5'-untranslated region (5' UTR) and share two CpG islands, DNA methylation only regulates the expression of HOXA11. Then, we found that HOXA11 and HOXA11-AS have an inverse interaction by transfecting their siRNAs and overexpression vectors into A549 and A549/DDP cells. A dual-luciferase reporter assay further confirmed that the overlapping 5'UTR is essential for the bidirectional regulation between HOXA11 and HOXA11-AS. Functional analysis showed that knockdown of HOXA11 expression in A549 cells induced DDP resistance and activated Akt/β-catenin signaling, while overexpression of HOXA11 in A549/DDP cells increased DDP sensitivity and inhibited Akt/β-catenin signaling. Moreover, HOXA11-AS knockdown in A549 cells increased DDP sensitivity and inhibited Akt/β-catenin signaling, while the overexpression of HOXA11-AS in A549/DDP cells induced DDP resistance and activated Akt/β-catenin signaling. In conclusion, our study demonstrates that the inverse interaction between HOXA11 and HOXA11-AS promotes DDP resistance in LUAD.

Entities:  

Keywords:  HOXA11; HOXA11-AS; Lung adenocarcinoma; methylation; resistance

Mesh:

Substances:

Year:  2019        PMID: 31144606      PMCID: PMC6691981          DOI: 10.1080/15592294.2019.1625673

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  42 in total

1.  DNA methylation analysis in liquid-based cytology for cervical cancer screening.

Authors:  Sophia Apostolidou; Richard Hadwin; Matthew Burnell; Allison Jones; Donna Baff; Nitisha Pyndiah; Tim Mould; Ian J Jacobs; Simon Beddows; Gabrijela Kocjan; Martin Widschwendter
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

2.  HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema.

Authors:  H A Golpon; M W Geraci; M D Moore; H L Miller; G J Miller; R M Tuder; N F Voelkel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Epigenetic resensitization to platinum in ovarian cancer.

Authors:  Daniela Matei; Fang Fang; Changyu Shen; Jeanne Schilder; Alesha Arnold; Yan Zeng; William A Berry; Tim Huang; Kenneth P Nephew
Journal:  Cancer Res       Date:  2012-05-01       Impact factor: 12.701

4.  Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling.

Authors:  Heather H Nelson; Carmen J Marsit; Brock C Christensen; E Andres Houseman; Milica Kontic; Joseph L Wiemels; Margaret R Karagas; Margaret R Wrensch; Shichun Zheng; John K Wiencke; Karl T Kelsey
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

5.  High-throughput DNA methylation profiling using universal bead arrays.

Authors:  Marina Bibikova; Zhenwu Lin; Lixin Zhou; Eugene Chudin; Eliza Wickham Garcia; Bonnie Wu; Dennis Doucet; Neal J Thomas; Yunhua Wang; Ekkehard Vollmer; Torsten Goldmann; Carola Seifart; Wei Jiang; David L Barker; Mark S Chee; Joanna Floros; Jian-Bing Fan
Journal:  Genome Res       Date:  2006-01-31       Impact factor: 9.043

6.  HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.

Authors:  Heidi Fiegl; Gudrun Windbichler; Elisabeth Mueller-Holzner; Georg Goebel; Matthias Lechner; Ian J Jacobs; Martin Widschwendter
Journal:  Int J Cancer       Date:  2008-08-01       Impact factor: 7.396

7.  Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.

Authors:  Tibor Rauch; Zunde Wang; Xinmin Zhang; Xueyan Zhong; Xiwei Wu; Sean K Lau; Kemp H Kernstine; Arthur D Riggs; Gerd P Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

8.  Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer.

Authors:  You-Wei Zhang; Yun Zheng; Jing-Zi Wang; Xiao-Xia Lu; Zhu Wang; Long-Bang Chen; Xiao-Xiang Guan; Jian-Dong Tong
Journal:  Epigenetics       Date:  2014-04-03       Impact factor: 4.528

9.  HOXA11 hypermethylation is associated with progression of non-small cell lung cancer.

Authors:  Jung-Ah Hwang; Bo Bin Lee; Yujin Kim; Seong-Eun Park; Kyun Heo; Seung-Hyun Hong; Young-Ho Kim; Joungho Han; Young Mog Shim; Yeon-Su Lee; Duk-Hwan Kim
Journal:  Oncotarget       Date:  2013-12

Review 10.  Systems biology of cisplatin resistance: past, present and future.

Authors:  L Galluzzi; I Vitale; J Michels; C Brenner; G Szabadkai; A Harel-Bellan; M Castedo; G Kroemer
Journal:  Cell Death Dis       Date:  2014-05-29       Impact factor: 8.469

View more
  12 in total

Review 1.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

2.  High expression of 14-3-3ơ indicates poor prognosis and progression of lung adenocarcinoma.

Authors:  Junfei Feng; Jing Leng; Changdi Zhao; Jie Guo; Yongbing Chen; Haifeng Li
Journal:  Oncol Lett       Date:  2022-05-12       Impact factor: 3.111

3.  A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma.

Authors:  Nan Shen; Jun Du; Hui Zhou; Nan Chen; Yi Pan; Jörg D Hoheisel; Zonghui Jiang; Ling Xiao; Yue Tao; Xi Mo
Journal:  Front Oncol       Date:  2019-12-03       Impact factor: 6.244

4.  Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma.

Authors:  Zhaodong Li; Fangyuan Qi; Fan Li
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

Review 5.  Methylation in HOX Clusters and Its Applications in Cancer Therapy.

Authors:  Ana Paço; Simone Aparecida de Bessa Garcia; Renata Freitas
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

6.  Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer.

Authors:  Lin Shi; Yuxin Gong; Lin Zhuo; Siyun Wang; Shaobing Chen; Bin Ke
Journal:  Ann Transl Med       Date:  2022-02

7.  Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.

Authors:  Yingying Zhang; Xin Liu; Liwen Liu; Jianhao Li; Qiuyue Hu; Ranran Sun
Journal:  Med Sci Monit       Date:  2020-02-22

8.  Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer.

Authors:  Jinyun Li; Meng Ye; Chongchang Zhou
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

9.  Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma.

Authors:  Youwei Zhang; He Du; Yang Li; Yuan Yuan; Bi Chen; Sanyuan Sun
Journal:  Cancer Sci       Date:  2020-01-17       Impact factor: 6.716

10.  Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.

Authors:  Feng-Jie Lin; Xian-Dong Lin; Lu-Ying Xu; Shi-Quan Zhu
Journal:  Mol Cells       Date:  2020-10-31       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.